文献速递角膜与眼表疾病眼底病与葡萄膜炎

VSX1错义突变的致病性及其与角膜病的关联

Investigating the Pathogenicity of VSX1 Missense Mutations and Their Association With Corneal Disease.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

本研究在体外检测VSX1错义突变对转录抑制活性、蛋白稳定性及亚细胞定位的影响,并建立VSX1 p.P247R小鼠模型观察角膜与视网膜表型。结果显示该突变增强转录抑制活性,但小鼠无可见角膜缺陷,仅出现异常视网膜电图反应;作者认为VSX1单独不似角膜病的主要致病因素。

要点

  • VSX1 p.P247R在体外增强转录抑制活性,但小鼠模型无可见角膜缺陷。
  • 该小鼠模型出现视网膜电图异常,表现为ON反应较OFF反应更突出。
  • 其他VSX1错义突变或增强抑制活性或不改变活性,VSX1单独不似主要致病因素。

核心结论

  • VSX1序列变异可改变转录活性,但在小鼠遗传模型中至少一种改变未导致角膜异常。
  • 不能排除VSX1作为角膜病风险因素的作用,但其单独不似起主要致病作用。

研究设计与样本

  • 在转染人胚胎肾293T细胞中,用荧光素酶报告基因检测、western blotting和免疫标记分别检测Vsx1转录抑制活性、蛋白稳定性和亚细胞定位。
  • 建立VSX1 p.P247R小鼠遗传模型进行体内致病性研究。
  • 开发未固定完整眼球的wholemount共聚焦成像方法,检查角膜形态、曲率和厚度。
  • 用免疫标记和视网膜电图检查视网膜表型。

主要发现

  • 对应人类VSX1 p.P247R的突变在体外导致转录抑制活性增强。
  • VSX1 p.P247R小鼠模型无任何可观察到的角膜缺陷。
  • 该小鼠模型视网膜电图异常,表现为全视网膜ON反应较OFF反应更突出。
  • 对其他VSX1错义突变的体外分析显示,它们或增强抑制活性或不改变活性。

临床怎么用

  • 对携带VSX1错义变异的角膜病家系,不宜仅凭变异推断其单独致病。
  • VSX1变异解读需结合功能实验与动物模型证据,并关注视网膜表型。
  • VSX1可作为角膜病风险因素考虑,但需谨慎评估其临床意义。

局限性

  • 研究采用小鼠遗传模型,结果外推至人类角膜病需谨慎。
  • 摘要未报告样本量、统计阈值及置信区间等定量信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Despite numerous studies associating Visual System Homeobox 1 (VSX1), with posterior polymorphous corneal dystrophy and keratoconus, its role in these diseases is unclear. Here we examine the pathogenicity of VSX1 missense mutations in vitro and in a mouse genetic model. METHODS: Vsx1 transcriptional repressor activity, protein stability, and subcellular localization activity, was examined using luciferase reporter-based assays, western blotting and immunolabeling, respectively, in transfected human embryonic kidney 293T cells. A genetic model for VSX1 p.P247R was generated to investigate pathogenicity of the mutation, in vivo. A wholemount confocal imaging approach on unfixed intact eyes was developed to examine corneal morphology, curvature, and thickness. Immunolabeling and electroretinography was used to examine retinal phenotype. RESULTS: A mutation corresponding to human VSX1 p.P247R led to enhanced transcriptional repressor activity, in vitro. A mouse model for VSX1 p.P247R did not have any observable corneal defect, but did exhibit an abnormal electroretinogram response characterized by a more prominent ON as opposed to OFF panretinal responsiveness. In vitro analysis of additional VSX1 missense mutations showed that they either enhanced repressor activity or did not alter activity. CONCLUSIONS: Our results indicate that although VSX1 sequence variants can alter transcriptional activity, in the context of a mouse genetic model, at least one of these changes does not lead to corneal abnormalities. While we cannot exclude a role for VSX1 as a risk factor for corneal disease, on its own, it does not appear to play a major causative role.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Litke AM, Samuelson S, Delaney KR, et al. Investigating the Pathogenicity of VSX1 Missense Mutations and Their Association With Corneal Disease. Invest Ophthalmol Vis Sci. 2018. PMID: 30535423. doi:10.1167/iovs.18-25490

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。